Abstract

We previously demonstrated the pivotal role of natural killer (NK) cells in islet graft loss during the early phase after intraportal syngeneic islet transplantation (IT). Liver-resident DX5− NK cells were reported to possess memory-like properties, distinguishing them from conventional DX5+ NK cells. Here, we investigated the impact of primary IT-induced liver DX5− NK cells on the engraftment of secondary-transplanted islets in mice. The culture of liver NK cells isolated from naive mice with TNF-α, IFN-γ, and IL-lβ, mimicking instant blood-mediated inflammatory reaction, led to significantly increased DX5− NK cell percentage among total liver NK cells. Consistently, the prolonged expansion of DX5− CD69+ TRAIL+ CXCR3+ NK cells was observed after intraportal IT of 300 syngeneic islets (marginal mass). In most diabetic mice, 400 syngeneic islets of primary IT were sufficient to achieve normoglycaemia, whereas the same mass after secondary IT failed to induce normoglycaemia in mice that received 200 syngeneic islets during primary IT. These findings indicated that liver-resident DX5− NK cells significantly expanded even after syngeneic IT, and that these memory-like NK cells may target both originally engrafted and secondary-transplanted islets. Furthermore, anti-TNF-α treatment suppressed the expansion of liver-resident DX5− NK cells, resulting in successful islet engraftment after sequential ITs.

Highlights

  • Clinical outcome of islet transplantation (IT) is becoming comparable to that of pancreas transplantation for a subgroup of patients with type 1 diabetes mellitus[1,2,3,4]

  • We further investigated the role of the CXCR3 molecule in IT

  • It has been demonstrated that high-mobility group box 1 (HMGB1) proteins released from transplanted islets, regardless whether allogeneic or syngeneic, trigger the activation of liver resident innate immune cells causing the early loss of transplanted islets[39]

Read more

Summary

Introduction

Clinical outcome of islet transplantation (IT) is becoming comparable to that of pancreas transplantation for a subgroup of patients with type 1 diabetes mellitus[1,2,3,4]. We have reported that liver mononuclear cells (LMNCs) contain a large population of NK cells, which possess increased cytotoxic activity in comparison with peripheral blood NK cells[17,18,19,20,21] Both TNF-related apoptosis-inducing ligand (TRAIL) expression on liver NK cells and their cytotoxicity against syngeneic and allogeneic islets significantly increased following intraportal IT6. Liver-resident NK cells lack DX5, the α2 integrin chain CD49b (a classical NK cell marker), and express TRAIL29 These DX5− NK cells are involved in the immunological memory response and their hematopoietic progenitor and precursor cells can be found in the liver[29]. We developed an in vivo model, which allowed us to compare the outcomes of the primary and secondary syngeneic ITs, and investigated the effects of the primary intraportal IT on the secondary IT by defining the population dynamics of liver resident DX5− memory-like NK cells

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call